BRCA2 and familial hyperaldosteronism: As CK expression among TN tumours in BRCA2 carriers was similar to the distribution among TN tumours in breast cases unselected for FH and not tested for mutation (P > 0.05), we used data from these controls for BRCA2 carriers in our analyses.